產(chǎn)品展示
- 重組人干擾素誘導(dǎo)蛋白-10?????Recombinant Human IP-10(CXCL10)300-125ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1616
- 重組人干擾素誘導(dǎo)蛋白-10?????Recombinant Human IP-10(CXCL10)300-125ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1650
- 重組人干擾素誘導(dǎo)蛋白-10?????Recombinant Human IP-10(CXCL10)300-125ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1824
- 重組人干擾素誘導(dǎo)蛋白-10?????Recombinant Human IP-10(CXCL10)300-125ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1642
- 重組人干擾素誘導(dǎo)蛋白-10?????Recombinant Human IP-10(CXCL10)300-125ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1554
- 重組人白介素-8(77a.a.)Recombinant Human IL-8(77a.a)(CXCL8)200-085ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1663
- 重組人白介素-8(77a.a.)Recombinant Human IL-8(77a.a)(CXCL8)200-085ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1645
- 重組人白介素-8(77a.a.)Recombinant Human IL-8(77a.a)(CXCL8)200-085ug/25ug/Peprotech時(shí)間:2025-09-30型號(hào):廠商性質(zhì):代理商瀏覽量:1766

